The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity
about
Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzeesReplicative homeostasis II: influence of polymerase fidelity on RNA virus quasispecies biology: implications for immune recognition, viral autoimmunity and other "virus receptor" diseasesCellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.Liver-directed gamma interferon gene delivery in chronic hepatitis C.Managing Occupational Risks for Hepatitis C Transmission in the Health Care SettingChronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNAFoxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis CClearance of low levels of HCV viremia in the absence of a strong adaptive immune responseMemory CD8+ T cells are required for protection from persistent hepatitis C virus infectionHepatic Transcriptome Analysis of Hepatitis C Virus Infection in Chimpanzees Defines Unique Gene Expression Patterns Associated with Viral ClearancePathogenesis of Hepatitis C Virus Infection in Tupaia belangeriProduction of infectious hepatitis C virus in tissue culture from a cloned viral genomeSpontaneous clearance of viral infections by mesoscopic fluctuationsMechanism of action of interferon and ribavirin in treatment of hepatitis C"Negative vaccination" by specific CD4 T cell tolerisation enhances virus-specific protective antibody responsesNovel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studiesInterferon type I gene expression in chronic hepatitis C.Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune responseHepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins.An overview of HCV molecular biology, replication and immune responses.Prospects for dendritic cell vaccination in persistent infection with hepatitis C virusRole of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis.Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection.Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection.Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.Natural killer cells: versatile roles in autoimmune and infectious diseases.Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance.HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance.The effects of hepatitis C virus core protein on functional responses in the NK cell line YTS.Increased frequency of CD56Bright NK-cells, CD3-CD16+CD56- NK-cells and activated CD4+T-cells or B-cells in parallel with CD4+CDC25High T-cells control potentially viremia in blood donors with HCV.Effect of IL-2 on hepatitis C virus RNA levels in patients co-infected with human immunodeficiency virus receiving HAART.Induction of hepatitis C virus (HCV)-specific T cells by needle stick injury in the absence of HCV-viraemia.Sustained response to interferon-alpha plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cells.Immunopathogenesis of Hepatitis C Virus Infection.
P2860
Q24685256-252703E8-F8A8-4454-8243-D3C3610DB606Q24814157-26A0F45C-7672-4B0C-96E6-969089D871D3Q26749249-951ACE91-AAD0-41B3-A8C3-DBE6DADF7E26Q27469468-9857E0A7-2E97-4079-9573-15851C353CEFQ27472673-04F20AD3-055E-48EC-A8F8-9539C973BD38Q27477626-0E1C03BA-E0CB-41DC-B642-7A3BD61B9E3DQ27478429-EC069359-20F5-4418-BF53-DB43C97984D2Q27480306-49CC2F8A-6A8E-463B-B52A-0BDD818202E8Q27480809-A9FD9CA8-9101-4A9F-84CB-A9F6D84D734CQ27485119-F2371B25-CB46-496D-91D0-2274E85D8AB8Q27487011-8595CE58-1844-44FB-9AD4-1E1348866449Q27490544-8AA931D5-1602-40CA-8BDB-3DA488835B2EQ27860899-371A529D-2BF9-42F1-9B64-74B395C0449BQ28484092-D7E83CCD-7294-4345-A771-7758CA2A12DDQ29619805-D9BAA963-53A0-4E2E-B81A-62091546FF0EQ33305432-6C8220D5-DB71-42BF-A96E-8F0BAB611D01Q33826844-7D741C20-2F9B-4350-9964-4602E8396F02Q34328120-ECF5F9B8-1E92-4BDE-9A71-CDABA7417F88Q34552781-8941BA66-1DAC-4860-AC90-00D2443A438BQ34765478-5E749C78-B716-4B67-9EBD-4417E96A5DB6Q34788785-794A0CE7-0626-4227-B4E0-0B5DEB6FF23DQ34916120-82216C98-5BAE-4238-A588-D2A49BF927D5Q35784239-BC927CE0-1564-4F2A-9ECB-9A8937B0B4F6Q35817615-D9054F27-E704-4E42-9147-065D3F498C6BQ35940716-34C2F34F-6337-4FC7-BDBD-9080EE7A0AEEQ36666331-98C67D9A-8F9A-4A8F-9385-7069736D68ACQ37381208-C6A5841F-E9E4-432E-9C6D-B77E5F9FFBF1Q37754682-DA9455A5-F264-4301-8002-595D5C0013E9Q39186289-9C11FE74-BE86-4E09-8C7D-1EB371ED5F2EQ39415291-66B40E30-5B06-40BA-ACEF-AC8661C52331Q39474013-505AF083-D6A6-45D6-BF74-FEEEE8F7564DQ42983326-D1D3D098-53B7-4FE9-B5DF-833D8D990876Q42993493-0FF36952-2D35-4DF6-BDF1-FCBE25834174Q45408928-802CAD77-FDEA-4C36-A697-B345648C1BEBQ50569016-597F8D5B-A15A-44BF-AF1C-9EF7CDA67B3EQ50934385-EA745DB0-7F41-4C25-AB25-2F0C4FA694D5
P2860
The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The Clearance of Hepatitis C V ...... ppearance of Acquired Immunity
@nl
The clearance of hepatitis C v ...... ppearance of acquired immunity
@ast
The clearance of hepatitis C v ...... ppearance of acquired immunity
@en
type
label
The Clearance of Hepatitis C V ...... ppearance of Acquired Immunity
@nl
The clearance of hepatitis C v ...... ppearance of acquired immunity
@ast
The clearance of hepatitis C v ...... ppearance of acquired immunity
@en
prefLabel
The Clearance of Hepatitis C V ...... ppearance of Acquired Immunity
@nl
The clearance of hepatitis C v ...... ppearance of acquired immunity
@ast
The clearance of hepatitis C v ...... ppearance of acquired immunity
@en
P2093
P2860
P3181
P1433
P1476
The clearance of hepatitis C v ...... ppearance of acquired immunity
@en
P2093
Barbara Rehermann
Harvey Alter
Krishna K Murthy
Marian Major
Michael B Havert
Michael Thomson
Michelina Nascimbeni
Sophia Gonzales
Stephen M Feinstone
T Jake Liang
P2860
P304
P3181
P356
10.1128/JVI.77.2.862-870.2003
P577
2003-01-01T00:00:00Z